speb/financial-data huggingface dataset:
CLRO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -14473000.00
CLRO balance_sheet (annual, 2024-12-31) — Finished Goods: 8800000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Finished Goods: 8800000.00
CLRO cash_flow (annual, 2024-12-31) — Free Cash Flow: -8919000.00
CLRO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
CLRO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -306000.00
CLRO income_statement (annual, 2024-12-31) — General And Administrative Expense: 1941000.00
CLRO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 1539000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 1539000.00
CLRO balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 2613000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 2613000.00
CLRO balance_sheet (annual, 2024-12-31) — Gross PPE: 750000.00
CLRO income_statement (annual, 2024-12-31) — Gross Profit: -194000.00
CLRO cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 98000.00
CLRO cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 0.00
CLRO cash_flow (quarterly, 2024-12-31) — Interest Paid Supplemental Data: -29000.00
CLRO balance_sheet (annual, 2024-12-31) — Inventory: 392000.00
CLRO balance_sheet (annual, 2024-12-31) — Invested Capital: 21331000.00
CLRO cash_flow (annual, 2024-12-31) — Investing Cash Flow: 4495000.00
CLRO balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 0.00
CLRO balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 0.00
CLRO balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
CLRO balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 0.00
CLRO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
CLRO balance_sheet (annual, 2024-12-31) — Leases: 205000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Leases: 205000.00
CLRO balance_sheet (annual, 2024-12-31) — Liabilities Heldfor Sale Non Current: 1154000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Liabilities Heldfor Sale Non Current: 1154000.00
CLRO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 514000.00
CLRO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 514000.00
CLRO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
CLRO cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: 0.00
CLRO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 68000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 68000.00
CLRO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
CLRO income_statement (annual, 2024-12-31) — Net Income: -8983000.00
CLRO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -8983000.00
CLRO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -1850000.00
CLRO income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: -7133000.00
CLRO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -8983000.00
CLRO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -1850000.00
CLRO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -8983000.00
CLRO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -8983000.00
CLRO cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -110000.00
CLRO cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: -22000.00
CLRO income_statement (annual, 2024-12-31) — Net Interest Income: 228000.00
CLRO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 4495000.00
CLRO cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 1338000.00
CLRO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
CLRO cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
CLRO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
CLRO cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
CLRO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 228000.00
CLRO balance_sheet (annual, 2024-12-31) — Net PPE: 750000.00
CLRO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -196000.00
CLRO cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -41000.00
CLRO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 21331000.00
CLRO income_statement (annual, 2024-12-31) — Normalized EBITDA: -1895000.00
CLRO income_statement (annual, 2024-12-31) — Normalized Income: -1850000.00
CLRO cash_flow (annual, 2024-12-31) — Operating Cash Flow: -8919000.00
CLRO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -82000.00
CLRO cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 20000.00
CLRO income_statement (annual, 2024-12-31) — Operating Income: -2135000.00
CLRO income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
CLRO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 1599533.00
CLRO balance_sheet (annual, 2024-12-31) — Other Current Assets: 3894000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 3894000.00
CLRO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 2852000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 2852000.00
CLRO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -306000.00
CLRO income_statement (annual, 2024-12-31) — Other Gand A: 1941000.00
CLRO income_statement (annual, 2024-12-31) — Other Income Expense: 155000.00
CLRO income_statement (quarterly, 2024-12-31) — Other Income Expense: -20000.00
CLRO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 1539000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 1539000.00
CLRO balance_sheet (annual, 2024-12-31) — Other Inventories: 392000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Other Inventories: 392000.00
CLRO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1079000.00
CLRO cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 1171000.00
CLRO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 7041000.00
CLRO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 1154000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 1154000.00
CLRO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 155000.00
CLRO income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -20000.00
CLRO balance_sheet (annual, 2024-12-31) — Other Properties: 750000.00
CLRO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 0.00
CLRO balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 0.00
CLRO balance_sheet (annual, 2024-12-31) — Payables: 76000.00
CLRO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 212000.00
CLRO balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 30000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 30000.00
CLRO balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CLRO balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 0.00
CLRO income_statement (annual, 2024-12-31) — Pretax Income: -1752000.00
CLRO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 23000.00
CLRO balance_sheet (annual, 2024-12-31) — Properties: 0.00
CLRO balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CLRO cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 79000.00
CLRO cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -110000.00
CLRO cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: -22000.00
CLRO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -5229000.00
CLRO cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: -534000.00
CLRO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -196000.00
CLRO cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -41000.00
CLRO balance_sheet (annual, 2024-12-31) — Raw Materials: 2424000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Raw Materials: 2424000.00
CLRO balance_sheet (annual, 2024-12-31) — Receivables: 2218000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Receivables: 2218000.00
CLRO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 194000.00
CLRO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 240000.00
CLRO cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
CLRO cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
CLRO income_statement (annual, 2024-12-31) — Research And Development: 3299000.00
CLRO income_statement (quarterly, 2024-12-31) — Research And Development: 755000.00
CLRO balance_sheet (annual, 2024-12-31) — Restricted Cash: 0.00
CLRO balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 0.00
CLRO balance_sheet (annual, 2024-12-31) — Retained Earnings: -10059000.00
CLRO cash_flow (annual, 2024-12-31) — Sale Of Investment: 9724000.00
CLRO cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 1872000.00
CLRO income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 4565000.00
CLRO income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 995000.00
CLRO income_statement (annual, 2024-12-31) — Selling General And Administration: 1941000.00
CLRO balance_sheet (annual, 2024-12-31) — Share Issued: 1599533.00
CLRO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 98000.00
CLRO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 21331000.00
CLRO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 21331000.00
CLRO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CLRO income_statement (annual, 2024-12-31) — Tax Provision: 98000.00
CLRO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
CLRO balance_sheet (annual, 2024-12-31) — Taxes Receivable: 10000.00
CLRO balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 10000.00
CLRO balance_sheet (annual, 2024-12-31) — Total Assets: 26544000.00
CLRO balance_sheet (annual, 2024-12-31) — Total Capitalization: 21331000.00
CLRO balance_sheet (annual, 2024-12-31) — Total Debt: 771000.00
CLRO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 21331000.00
CLRO income_statement (annual, 2024-12-31) — Total Expenses: 2135000.00
CLRO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 5213000.00
CLRO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 7791000.00
CLRO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1668000.00
CLRO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -2135000.00
CLRO income_statement (annual, 2024-12-31) — Total Other Finance Cost: -228000.00
CLRO income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: 36000.00
CLRO balance_sheet (annual, 2024-12-31) — Working Capital: 15208000.00
CLRO income_statement (quarterly, 2025-03-31) — +Operating Expense: 799000.00
CLRO income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
CLRO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1910000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1909000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 32700000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -411000.00
CLRO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 1649904.00
CLRO income_statement (quarterly, 2025-03-31) — Basic EPS: -1.71
CLRO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 1417000.00
CLRO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -30000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 460000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 26000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 961000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 961000.00
CLRO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 1000000.00
CLRO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
CLRO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -2644000.00
CLRO cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Financing Activities: 7000.00
CLRO cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Investing Activities: -18000.00
CLRO cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Operating Activities: 1212000.00
CLRO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 187000.00
CLRO cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -18000.00
CLRO cash_flow (quarterly, 2025-03-31) — Change In Inventory: 0.00
CLRO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -80000.00
CLRO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -5000.00
CLRO cash_flow (quarterly, 2025-03-31) — Change In Payable: 187000.00
CLRO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 169000.00
CLRO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 0.00
CLRO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 275000.00
CLRO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 89000.00
CLRO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 293000.00
CLRO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -443000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Common Stock: 26000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 19514000.00
CLRO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 1000000.00
CLRO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 27000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 1628000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Current Assets: 17087000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 12000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 12000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3550000.00
CLRO cash_flow (quarterly, 2025-03-31) — Depreciation: 78000.00
CLRO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 78000.00
CLRO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 78000.00
CLRO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 1649904.00
CLRO income_statement (quarterly, 2025-03-31) — Diluted EPS: -1.71
CLRO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -2834000.00
CLRO income_statement (quarterly, 2025-03-31) — EBIT: -826000.00
CLRO income_statement (quarterly, 2025-03-31) — EBITDA: -748000.00
CLRO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -13000.00
CLRO cash_flow (quarterly, 2025-03-31) — End Cash Position: 961000.00
CLRO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 1007000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Finished Goods: 7587000.00
CLRO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1432000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -319000.00
CLRO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 799000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1500000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 2320000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1114000.00
CLRO income_statement (quarterly, 2025-03-31) — Gross Profit: -27000.00
CLRO cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
CLRO cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 0.00
CLRO balance_sheet (quarterly, 2025-03-31) — Inventory: 9866000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 19514000.00
CLRO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -18000.00
CLRO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 1000000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 460000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 460000.00
CLRO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 1000000.00
CLRO income_statement (quarterly, 2025-03-31) — Net Income: -2834000.00
CLRO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -2834000.00
CLRO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -814000.00
CLRO income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: -2020000.00
CLRO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -2834000.00
CLRO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -814000.00
CLRO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -2834000.00
CLRO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -2834000.00
CLRO cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -13000.00
CLRO income_statement (quarterly, 2025-03-31) — Net Interest Income: 0.00
CLRO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
CLRO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 0.00
CLRO balance_sheet (quarterly, 2025-03-31) — Net PPE: 1114000.00
CLRO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -5000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 18014000.00
CLRO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -748000.00
CLRO income_statement (quarterly, 2025-03-31) — Normalized Income: -814000.00
CLRO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1432000.00
CLRO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -9000.00
CLRO income_statement (quarterly, 2025-03-31) — Operating Income: -826000.00
CLRO income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
CLRO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 1732866.00
CLRO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 4324000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -319000.00
CLRO income_statement (quarterly, 2025-03-31) — Other Gand A: 799000.00
CLRO income_statement (quarterly, 2025-03-31) — Other Income Expense: 12000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1500000.00
CLRO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 272000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 4978000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 1155000.00
CLRO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 12000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Other Properties: 1114000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Payables: 1910000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 3538000.00
CLRO income_statement (quarterly, 2025-03-31) — Pretax Income: -814000.00
CLRO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
CLRO cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 6000.00
CLRO cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -13000.00
CLRO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
CLRO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -17000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Raw Materials: 2279000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Receivables: 1936000.00
CLRO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 27000.00
CLRO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 78000.00
CLRO income_statement (quarterly, 2025-03-31) — Research And Development: 0.00
CLRO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -12893000.00
CLRO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
CLRO cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 12000.00
CLRO income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 0.00
CLRO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 799000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Share Issued: 1732866.00
CLRO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 23000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 19514000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 18014000.00
CLRO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CLRO income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
CLRO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CLRO balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 27000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Total Assets: 24679000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 19514000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Total Debt: 460000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 19514000.00
CLRO income_statement (quarterly, 2025-03-31) — Total Expenses: 826000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 5165000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 7592000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1615000.00
CLRO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -826000.00
CLRO balance_sheet (quarterly, 2025-03-31) — Working Capital: 13537000.00
CLRO income_statement (quarterly, 2025-06-30) — +Operating Expense: 4328000.00
CLRO income_statement (quarterly, 2025-06-30) — +Total Revenue: 1916000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 2029000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1053000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 32738000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -267000.00
CLRO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 1733307.00
CLRO income_statement (quarterly, 2025-06-30) — Basic EPS: -2.64
CLRO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 961000.00
CLRO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -3000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 405000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1132000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1132000.00
CLRO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 3000000.00
CLRO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -21000.00
CLRO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 76000.00
CLRO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 37000.00
CLRO cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 776000.00
CLRO cash_flow (quarterly, 2025-06-30) — Change In Inventory: 2345000.00
CLRO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -64000.00
CLRO cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 0.00
CLRO cash_flow (quarterly, 2025-06-30) — Change In Payable: 37000.00
CLRO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 813000.00
CLRO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -229000.00
CLRO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 999000.00
CLRO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 4134000.00
CLRO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 1000000.00
CLRO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1854000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Common Stock: 2000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 14946000.00
CLRO cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
CLRO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2147000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 2450000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Current Assets: 16869000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Current Debt: 3008000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 3008000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 12000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 12000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 7499000.00
CLRO cash_flow (quarterly, 2025-06-30) — Depreciation: 313000.00
CLRO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 313000.00
CLRO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 313000.00
CLRO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 1733307.00
CLRO income_statement (quarterly, 2025-06-30) — Diluted EPS: -2.64
CLRO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -4572000.00
CLRO income_statement (quarterly, 2025-06-30) — EBIT: -4559000.00
CLRO income_statement (quarterly, 2025-06-30) — EBITDA: -4246000.00
CLRO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -5000.00
CLRO cash_flow (quarterly, 2025-06-30) — End Cash Position: 2810000.00
CLRO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 2993000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Finished Goods: 6755000.00
CLRO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1169000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -329000.00
CLRO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1586000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1453000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 1320000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 977000.00
CLRO income_statement (quarterly, 2025-06-30) — Gross Profit: -231000.00
CLRO cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 0.00
CLRO cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 0.00
CLRO balance_sheet (quarterly, 2025-06-30) — Inventory: 8846000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 17954000.00
CLRO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -3000.00
CLRO cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
CLRO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 405000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 405000.00
CLRO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CLRO balance_sheet (quarterly, 2025-06-30) — Net Debt: 1876000.00
CLRO income_statement (quarterly, 2025-06-30) — Net Income: -4572000.00
CLRO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -4572000.00
CLRO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -4572000.00
CLRO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -4572000.00
CLRO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -4572000.00
CLRO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -4572000.00
CLRO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -4572000.00
CLRO cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -3000.00
CLRO income_statement (quarterly, 2025-06-30) — Net Interest Income: -8000.00
CLRO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
CLRO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -8000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Net PPE: 977000.00
CLRO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 0.00
CLRO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 13493000.00
CLRO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -4246000.00
CLRO income_statement (quarterly, 2025-06-30) — Normalized Income: -4572000.00
CLRO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1136000.00
CLRO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 0.00
CLRO income_statement (quarterly, 2025-06-30) — Operating Income: -4559000.00
CLRO income_statement (quarterly, 2025-06-30) — Operating Revenue: 1916000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1734249.00
CLRO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 4131000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 3008000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -329000.00
CLRO income_statement (quarterly, 2025-06-30) — Other Gand A: 1586000.00
CLRO income_statement (quarterly, 2025-06-30) — Other Income Expense: 3000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1453000.00
CLRO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 56000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 4706000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 1155000.00
CLRO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 3000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Other Properties: 977000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Payables: 2029000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 4479000.00
CLRO income_statement (quarterly, 2025-06-30) — Pretax Income: -4564000.00
CLRO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
CLRO cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: -145000.00
CLRO cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -3000.00
CLRO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
CLRO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: 0.00
CLRO balance_sheet (quarterly, 2025-06-30) — Raw Materials: 2091000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Receivables: 1082000.00
CLRO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2147000.00
CLRO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 313000.00
CLRO income_statement (quarterly, 2025-06-30) — Research And Development: 1359000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 1678000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -17465000.00
CLRO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
CLRO cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
CLRO income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 1383000.00
CLRO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2969000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Share Issued: 1734249.00
CLRO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 21000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 14946000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 13493000.00
CLRO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CLRO income_statement (quarterly, 2025-06-30) — Tax Provision: 8000.00
CLRO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CLRO balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 29000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Total Assets: 24005000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 14946000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Total Debt: 3413000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 14946000.00
CLRO income_statement (quarterly, 2025-06-30) — Total Expenses: 6475000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 9059000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 7136000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 1560000.00
CLRO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -4559000.00
CLRO income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 8000.00
CLRO balance_sheet (quarterly, 2025-06-30) — Working Capital: 9370000.00
CLRO income_statement (quarterly, 2025-09-30) — +Operating Expense: 827000.00
CLRO income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
CLRO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 118000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 32726000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 7442000.00
CLRO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 1734250.00
CLRO income_statement (quarterly, 2025-09-30) — Basic EPS: -7.92
CLRO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 2810000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 566000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 3028000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 101000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 101000.00
CLRO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: 0.00
CLRO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -34000.00
CLRO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 0.00
CLRO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -754000.00
CLRO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -182000.00
CLRO cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -937000.00
CLRO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -61000.00
CLRO cash_flow (quarterly, 2025-09-30) — Change In Payable: -182000.00
CLRO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -1119000.00
CLRO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -4565000.00
CLRO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -2035000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Common Stock: 2000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 435000.00
CLRO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CLRO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 27000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 181000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Current Assets: 8598000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 218000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 218000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 3751000.00
CLRO cash_flow (quarterly, 2025-09-30) — Depreciation: -187000.00
CLRO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: -187000.00
CLRO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: -187000.00
CLRO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 1734250.00
CLRO income_statement (quarterly, 2025-09-30) — Diluted EPS: -7.92
CLRO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -13736000.00
CLRO income_statement (quarterly, 2025-09-30) — EBIT: -854000.00
CLRO income_statement (quarterly, 2025-09-30) — EBITDA: -854000.00
CLRO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -11000.00
CLRO cash_flow (quarterly, 2025-09-30) — End Cash Position: 764000.00
CLRO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -34000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Finished Goods: 392000.00
CLRO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -754000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -335000.00
CLRO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 827000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 546000.00
CLRO income_statement (quarterly, 2025-09-30) — Gross Profit: -27000.00
CLRO cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 29000.00
CLRO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 28000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Inventory: 392000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 435000.00
CLRO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 0.00
CLRO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CLRO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
CLRO balance_sheet (quarterly, 2025-09-30) — Liabilities Heldfor Sale Non Current: 1155000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 348000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 348000.00
CLRO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CLRO income_statement (quarterly, 2025-09-30) — Net Income: -13736000.00
CLRO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -13736000.00
CLRO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -871000.00
CLRO income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: -12865000.00
CLRO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -13736000.00
CLRO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -871000.00
CLRO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -13736000.00
CLRO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -13736000.00
CLRO cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: 0.00
CLRO income_statement (quarterly, 2025-09-30) — Net Interest Income: -20000.00
CLRO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 0.00
CLRO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
CLRO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -20000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Net PPE: 546000.00
CLRO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
CLRO cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 0.00
CLRO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 3461000.00
CLRO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -854000.00
CLRO income_statement (quarterly, 2025-09-30) — Normalized Income: -871000.00
CLRO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -754000.00
CLRO income_statement (quarterly, 2025-09-30) — Operating Income: -854000.00
CLRO income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
CLRO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1734250.00
CLRO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 3234000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -335000.00
CLRO income_statement (quarterly, 2025-09-30) — Other Gand A: 827000.00
CLRO income_statement (quarterly, 2025-09-30) — Other Income Expense: 4000.00
CLRO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 17564000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 329000.00
CLRO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 4000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Other Properties: 546000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Payables: 118000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 299000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Preferred Securities Outside Stock Equity: 758000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 3026000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 3026000.00
CLRO income_statement (quarterly, 2025-09-30) — Pretax Income: -870000.00
CLRO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: -34000.00
CLRO cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: 0.00
CLRO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 0.00
CLRO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
CLRO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 27000.00
CLRO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: -187000.00
CLRO income_statement (quarterly, 2025-09-30) — Research And Development: 0.00
CLRO balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 663000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -31958000.00
CLRO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
CLRO cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
CLRO income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 0.00
CLRO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 827000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Share Issued: 1734250.00
CLRO cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 0.00
CLRO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 22000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 3461000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 435000.00
CLRO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CLRO income_statement (quarterly, 2025-09-30) — Tax Provision: 1000.00
CLRO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CLRO balance_sheet (quarterly, 2025-09-30) — Total Assets: 9473000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 3461000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Total Debt: 566000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 3461000.00
CLRO income_statement (quarterly, 2025-09-30) — Total Expenses: 854000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 6012000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 875000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2261000.00
CLRO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -854000.00
CLRO income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 20000.00
CLRO balance_sheet (quarterly, 2025-09-30) — Working Capital: 4847000.00
CLRO income_statement (annual, 2025-12-31) — +Operating Expense: 4068000.00
CLRO income_statement (quarterly, 2025-12-31) — +Operating Expense: 888000.00
CLRO income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
CLRO income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
CLRO balance_sheet (annual, 2025-12-31) — Accounts Payable: 30000.00
CLRO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 30000.00
CLRO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: 0.00
CLRO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: 0.00
CLRO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 35767000.00
CLRO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 35767000.00
CLRO balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 604000.00
CLRO balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 604000.00
CLRO income_statement (annual, 2025-12-31) — Basic Average Shares: 1765654.00
CLRO income_statement (annual, 2025-12-31) — Basic EPS: -14.77
CLRO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1417000.00
CLRO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 764000.00
CLRO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 513000.00
CLRO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 513000.00
CLRO balance_sheet (annual, 2025-12-31) — Capital Stock: 2000.00
CLRO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2000.00
CLRO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 220000.00
CLRO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 220000.00
CLRO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 220000.00
CLRO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 220000.00
CLRO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: 0.00
CLRO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
CLRO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 3966000.00
CLRO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 0.00
CLRO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
CLRO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 21000.00
CLRO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -14554000.00
CLRO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -11232000.00
CLRO cash_flow (annual, 2025-12-31) — Cash Flow From Discontinued Operation: 9944000.00
CLRO cash_flow (quarterly, 2025-12-31) — Cash Flow From Discontinued Operation: 11191000.00
CLRO cash_flow (annual, 2025-12-31) — Change In Account Payable: -46000.00
CLRO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -88000.00
CLRO cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 289000.00
CLRO cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 468000.00
CLRO cash_flow (annual, 2025-12-31) — Change In Inventory: 39000.00
CLRO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -258000.00
CLRO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -53000.00
CLRO cash_flow (annual, 2025-12-31) — Change In Payable: -46000.00
CLRO cash_flow (quarterly, 2025-12-31) — Change In Payable: -88000.00
CLRO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 243000.00
CLRO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 380000.00
CLRO cash_flow (annual, 2025-12-31) — Change In Working Capital: 24000.00
CLRO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 366000.00
CLRO cash_flow (annual, 2025-12-31) — Changes In Cash: -644000.00
CLRO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -20000.00
CLRO balance_sheet (annual, 2025-12-31) — Common Stock: 2000.00
CLRO balance_sheet (quarterly, 2025-12-31) — Common Stock: 2000.00
CLRO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: 0.00
CLRO cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: 0.00
CLRO balance_sheet (annual, 2025-12-31) — Common Stock Equity: -714000.00
CLRO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -714000.00
CLRO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 1000000.00
CLRO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CLRO income_statement (annual, 2025-12-31) — Cost Of Revenue: 328000.00
CLRO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 248000.00
CLRO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 113000.00
CLRO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 113000.00
CLRO balance_sheet (annual, 2025-12-31) — Current Assets: 1696000.00
CLRO balance_sheet (quarterly, 2025-12-31) — Current Assets: 1696000.00
CLRO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 223000.00
CLRO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 223000.00
CLRO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 223000.00
CLRO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 223000.00
CLRO balance_sheet (annual, 2025-12-31) — Current Liabilities: 1487000.00